Bowel Cancer and Biomarker Research Lab

Bowel cancer, also known as colorectal cancer, is the second most common cancer in Australian men and women. It affects 1 in 13 people. It is also Australia’s second deadliest cancer, with over 5,000 people dying each year. Early detection through screening can improve survival rates, however further research is needed to help find cures and prevent the disease.

The Bowel Cancer and Biomarker Laboratory at the Kolling Institute uses advanced technologies to study the genes and proteins responsible for bowel cancers growing and spreading. Our aim is to use a patient’s own molecular information to understand the risk of bowel cancer developing and to guide treatment options. As part of our research, we are studying how to control bowel polyp growth, which are precursors to cancer. We are doing this through diet and chemotherapy drugs.

Mark-P-Molloy Prof Mark P. Molloy, PhD | Lawrence Penn Chair of Bowel Cancer Research

The University of Sydney | Northern Clinical School
Faculty of Medicine and Health
Honorary Professor | Dept. Molecular Sciences, Macquarie University
Secretary | Australasian Proteomics Society

Dr Jun Li PhD

Postdoctoral Research Fellow


Dr Benita Tse

Postdoctoral Scientist

Matthew McKay - Senior Research Officer

Bharat Venkatesh Gunappa - Research Officer

Atul Bhatnagar - Senior Technical Officer

(Vo Van) Anh Pham - Honours Student

Miguel Castaneda - Research Assistant

Current bowel cancer research focuses on:

  • Why and how some bowel polyps become cancers
  • Which bowel tumours are likely to spread
  • Molecular make-up of colorectal tumours
  • Early detection of disease recurrence

Our research is facilitated by specimens from clinical projects we run including:

  • Sydney 1000 bowel cancer study
  • IMAP Bowel polyp study

Bowel Cancer and Biomarker Research related information

Events, News and Seminars

New approach revolutionising ovarian cancer research

New approach revolutionising ovarian cancer research

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kol..... Read more

Category: New Treatment, Research Excellence

Recognition of our impact on the world stage

Recognition of our impact on the world stage

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than ..... Read more

Category: Research Excellence

Philanthropic funds creating travel opportunities

Philanthropic funds creating travel opportunities

A collection of emerging research leaders will have the chance to broaden their research experience ..... Read more

Category: Awards, Research Excellence